{"cmr":"kr-cm-kg/KOSDAQ/293780","since":null,"total":30,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-10-14","event_type":"corporate_news","title":"투자판단관련주요경영사항(임상시험결과)              (조영제유발급성신장손상(CIAKI) 치료제 Isuzinaxib(APX115)의 임상시험 제2상 Topline data수령)","reference":"20261014900633","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261014900633","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"K27Ff9SsRK8lWepqW1URC0Ro6qqbAu5lttswIbNWA08hSLiFWNW17WRBYZLjR8R4dFvXfmki8-NI7D_dtRpxDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-09-02","event_type":"corporate_news","title":"기업설명회(IR)개최","reference":"20260902900270","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260902900270","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"trVmbVCT4NHb9RjBZ0b6HFDZW05X5h90NgTCB_d_rj3TEGCcwHFhGv1KFTCzWDgen1jjdZZNfyAyCud7f-TIDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-08-24","event_type":"corporate_news","title":"전환사채(해외전환사채포함)발행후만기전사채취득","reference":"20260824900106","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260824900106","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"36Dk5sy4uJ4LOouzblNbaEmW_Fk4sxqOoUs6Vgdb1CgM0yYHQDm7hD4M1AQlKZvFvnHyZKw_pevFPOUmRXnbCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-08-14","event_type":"results","title":"반기보고서 (2026.06)","reference":"20260814002182","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260814002182","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qK_uES0gDGBPCtxIQpKu7TjIFQk6o3UdH5ZTgFBNb7yKo_OeUg5r1g6P-4h6jj1_vnMp3O5AR4iat3OjK4qNAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-07-24","event_type":"corporate_news","title":"전환가액의조정","reference":"20260724900529","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260724900529","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rXYMr26pCEYT_NqLTfiTXrhiMFi3y-mThH-_Bs3Mvhe0-WacqLBJKAi_W-5BJviOCgJzB_A_XTpG6jw3iJGPDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-06-16","event_type":"corporate_news","title":"투자판단관련주요경영사항              (ABF101의 경구투여 시 안전성, 내약성 및 약동학을 평가하기 위한 단회 및 반복 투여, 단계적 용량증량, 제1상 임상시험에 대한 미국 FDA Remove Clinical Hold 공문 수령)","reference":"20260616900253","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260616900253","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DZQGdtSoHP2JAGNVXk57tMJKhPM_lqoJMZN5VnfeKjoOAPpjUubRs7o93IDzvyuMJWwoDsYIRgDTqGFQESTEAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-05-15","event_type":"results","title":"분기보고서 (2026.03)","reference":"20260515002692","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260515002692","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PHLdIsZucOmORMIgLvTyuxFmZDb5ZtowS52SlY3IBvWIljq6O-9KWa07DvcixB3M9Ox3WiU-c0aFm8MkiCAZDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-04-14","event_type":"corporate_news","title":"투자판단관련주요경영사항(임상시험계획승인신청등결정)              (조영제유발급성신장손상(CIAKI)치료제 Isuzinaxib(APX115)의 미국 FDA 2상 임상시험계획(IND)변경승인)","reference":"20260414900669","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260414900669","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EU0H4guL61SfOd12jrEyeNdnd-TNpPoVAkgmzc-CmiR-rDem7W_kHNJDizS6HOemvPNmT2T3A-nhtU11Zy4xDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-04-06","event_type":"corporate_news","title":"기업설명회(IR)개최","reference":"20260406900439","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260406900439","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"QNPcSrT2zhyFhVi1g77azSuFf77Ae0tMNDDs0ttw9iu5P5orE7OZ-hSau9aHyfXA482SOnrLHsypn51vABnHCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-04-01","event_type":"corporate_news","title":"본점소재지변경","reference":"20260401900764","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260401900764","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"eo-NyQQn4NM3Qbfj--ece8wUzZjzZBZ8WFaviUIZ0H8wDXyBH6534Ei8wRLhaK7QbSvGp7kyO5a6nEO3KjcfAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-31","event_type":"agm_egm","title":"정기주주총회결과","reference":"20260331901759","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260331901759","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"HAI1oyOtB0vmBBuiubkIWqDe0kzDaMbxJzltiujtjv50iXs5FTgzUDv8ZcThtQbBrSuZKplVDMJO2q0uxgITAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-27","event_type":"corporate_news","title":"기업설명회(IR)개최","reference":"20260327900798","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260327900798","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xTtLiFUkYpz3iUG_W-WKvPAGwzmYfNySSau-B9OvRuorL5Co_q7JF9eNZeh8YQxwkIEVLH49PB-ycoHvsT04Cg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-26","event_type":"corporate_news","title":"기업설명회(IR)개최","reference":"20260326900104","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260326900104","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"iqFuJ-MsuYE3dtzXeTREpABGuwvOM0IKkSY2c8Y6pNZbwuw0HR52n6CBhu0p6My6wt4poHmTnfKjEFwnSshxAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-23","event_type":"regulatory_filing","title":"감사보고서제출","reference":"20260323901638","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260323901638","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"I3CrT_W9AVoas7ihoxQ6ArRs0wJT1w53LjANp1SlM-HhE985KisPgzJhP59iZ4w7A6tu8RPno7zjYOBU0darBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-23","event_type":"results","title":"사업보고서 (2025.12)","reference":"20260323001542","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260323001542","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 연","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"10p5BB0J5ohqxGDVPGo7b3iM5-CSh4SX6buKJ0Yt0kQ4XaVZr-0H_y3blweEwP4XtdgcI_S1-RJxmOd6ZLTDBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-16","event_type":"agm_egm","title":"주주총회소집공고","reference":"20260316001456","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260316001456","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"E_WGme4ruTT5FQotEo7heOqV9GyIQt_R-AV0XRtn8jDKiR2G-xC7-Ltpz25fcCS1LWFNtXCzUyCMOAIeOI9_Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-16","event_type":"agm_egm","title":"[기재정정]주주총회소집결의","reference":"20260316900526","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260316900526","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fSwtmrrWT_lmEg75VHJqUA4YsaH849xKxJGhPJ4aWTumOBV219grjYEIqtl-qnUhe_sgQwKwtxGTyxiNbOXlCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-13","event_type":"corporate_news","title":"투자판단관련주요경영사항(임상시험계획승인신청등결정)              (조영제유발급성신장손상(CIAKI) 치료제 Isuzinaxib(APX115)의 국내 2상 임상시험계획(IND) 변경승인)","reference":"20260313902284","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260313902284","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CJFgWoHRxWuZzEovZxI4do3B97BUMeXm5B_1xHWvQTPTBKwclbGeOL8OaLWDLltsvF-jPs3oPtwe8Y7sm6wrDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-03-13","event_type":"corporate_news","title":"투자판단관련주요경영사항(임상시험계획변경승인신청)              (조영제유발급성신장손상(CIAKI)치료제 Isuzinaxib(APX115)의 미국 FDA 2상 임상시험계획(IND)변경승인신청)","reference":"20260313900460","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260313900460","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"OMSxBkiKufpv9HOorWAG8fSltp7gmv2VPhoSS5nec6zvNPEdZW5X8vKQ-pjuVLcJyU-goKoJ7aIir8U99kuQDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-02-23","event_type":"corporate_news","title":"투자판단관련주요경영사항              (ABF101의 경구투여 시 안전성, 내약성 및 약동학을 평가하기 위한 단회 및 반복 투여, 단계적 용량증량, 제1상 임상시험에 대한 미국 FDA Clinical Hold 공문 수령)","reference":"20260223900498","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260223900498","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rSI-uJ-ugijit7wOXGjbemFp-7VA7YTu4NF-9_0PSFtG7G0raPzipBq-9zl1BAmGwzJY78K14HMZ_Ot5GTS4BQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-02-09","event_type":"agm_egm","title":"주주총회소집결의","reference":"20260209901483","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260209901483","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코정","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"03Ki4SSeF9z7jy32CFYeU9w187SSuJyGX1M28nZ1HIeIiw0OeYbWmvb3RJBkBIxXBI8e42gnCowSeNZXH926CQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-02-09","event_type":"corporate_news","title":"주식매수선택권부여에관한신고","reference":"20260209000663","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260209000663","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"91ex2RdrhGGLQKSCQCMHhZHbCd-YlSJC2K6mEvPsrYirT8a9aF_z3bXzFv6-EuHiW6xLckNQPLS-W4gIz8bfAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-02-09","event_type":"results","title":"매출액또는손익구조30%(대규모법인은15%)이상변동","reference":"20260209901227","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260209901227","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"JLMaM1IpMO9MmnfrIm1BO6pxKxprKpy403FdJNbXVu_kDpw7ta5rXbR7RW97ZV7zFVm2OAbC1i-RX4WbB6jCAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2026-02-06","event_type":"corporate_news","title":"투자판단관련주요경영사항(임상시험계획변경승인신청)              (조영제유발급성신장손상(CIAKI) 치료제 Isuzinaxib(APX115)의 국내 2상 임상시험계획(IND) 변경승인신청)","reference":"20260206901542","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260206901542","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RaAlYEaodBDWPNmlUlXNXlGqHZrvW-FNMKwbxwHBneAQqyxzK-BHigiCjpS1GbccPVXu6atBMkA0T9t8Y5tECA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2025-12-24","event_type":"corporate_news","title":"전환가액의조정","reference":"20251224900105","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251224900105","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DzPkG3fBHsOAHVlAxSTjvxIwxcOhaiQ2B9l_vWkmLb7AgEP1A6igICwaWs3qRE6Y9ajrU4pUGWlI_QEaV4hJAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2025-12-23","event_type":"corporate_news","title":"전환청구권행사","reference":"20251223900469","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251223900469","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CKd7qRPOJOqz8BQBsCDj9iPASiM-s3-FdiMFwNR-tDxgBrA1s3RtOgDDMlyzhWK-zwG6db9zncY4q_flohofAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2025-12-22","event_type":"corporate_news","title":"전환청구권행사","reference":"20251222900483","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251222900483","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"kzmhtXD91rFLb0tYbA0ikUaddmHf9ed3uMg4K-C9BSwBTbTbQL1uiB1RX_XSLNlyX2yck6v52iyAaJizy-RaAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2025-12-16","event_type":"corporate_news","title":"주주명부폐쇄기간또는기준일설정","reference":"20251216900553","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251216900553","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"sc7P8jxw3HTYvNUrttiV97A-hRYwkFKdUFm-oQIkK6vp0Az4lbyZEqF1k3tvcvB5SkiSKikQHNqZZ-W8peA2Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2025-11-14","event_type":"results","title":"분기보고서 (2025.09)","reference":"20251114001666","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251114001666","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"L1rJlIYcLO7R0yZd3RedEDMARNxC5NqHFjAQfiPPHob0wRoo4uCjJg_Aa6tpS6WOhDjBVIDxHCD3peYPBoTnDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/293780","date":"2025-10-23","event_type":"corporate_news","title":"투자판단관련주요경영사항(임상시험계획승인신청등결정)              (ABF101의 미국 FDA 제1상 임상시험계획(IND)승인)","reference":"20251023900219","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251023900219","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 압타바이오; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0oathWkN8yqKvNla_kc-ul87B5DMGsEvwL0OdOjW6ekWeeNpc1nrqAg5ZmVaDqcYq4shxhTHLKwzV7YIg-MwBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}